HR 4710 · 116th Congress 2019–2021, ended

Pharmaceutical Independence Long-Term Readiness Reform Act

Latest action · Nov 8, 2019 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedOct 17, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Pharmaceutical Independence Long-Term Readiness Reform Act

This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.

Cosponsors 19

Members who signed on, in the order they did. Signatures ran from Oct 17, 2019 to May 19, 2020; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-MOVicky HartzlerOriginalOct 17, 2019
D-TXVeronica EscobarNov 8, 2019
R-MTGreg GianforteFeb 14, 2020
R-PABrian K. FitzpatrickMar 2, 2020
R-NYElise M. StefanikApr 17, 2020
D-TXSheila Jackson LeeApr 21, 2020
R-NEDon BaconApr 28, 2020
R-MSMichael GuestApr 28, 2020
R-MNPete StauberMay 5, 2020
R-TXRon WrightMay 5, 2020
R-COScott R. TiptonMay 5, 2020
R-FLBill PoseyMay 8, 2020
R-NJChristopher H. SmithMay 8, 2020
D-HIEd CaseMay 8, 2020
D-TNSteve CohenMay 8, 2020

Committees 3

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseArmed Services Committee
Referred Oct 17, 2019
HouseVeterans' Affairs Committee
Referred Oct 17, 2019
Health Subcommittee
Referred Nov 8, 2019
HouseFinancial Services Committee
Referred Oct 17, 2019

Actions 4

Everything that happened, newest first.

  1. Nov 8, 2019Referred to the Subcommittee on Health.
  2. Oct 17, 2019Introduced in House
  3. Oct 17, 2019Sponsor introductory remarks on measure. (CR E1297-1298)
  4. Oct 17, 2019Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
House · ExtensionsDebate and remarks E1297Lists H8227H.R. 4710–4732John Garamendi D-CAOct 17, 2019

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8 of the U.S. Constitution.

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 164, October 17, 2019, page H8227.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
H.A.S.C. No. 116-84DEPARTMENT OF DEFENSE COVID-19 RESPONSE TO DEFENSE INDUSTRIAL BASE CHALLENGES85 pagesArmed Services CommitteeJun 10, 2020
S. Hrg. 116-490COVID-19 AND BEYOND: OVERSIGHT OF THE FDA'S FOREIGN DRUG MANUFACTURING INSPECTION PROCESS231 pagesFinance CommitteeJun 2, 2020

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

ProductTitleKindPublished
R46304COVID-19: China Medical Supply Chains and Broader Trade IssuesReportDec 23, 2020

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To direct the Secretary of Defense to include in each national defense strategy steps to strengthen the United States industrial base and to assure an uninterrupted supply of medicines, and for other purposes.
Short Title(s) as Introduced
Pharmaceutical Independence Long-Term Readiness Reform Act

Subjects

Assigned by the Library of Congress. Policy area: Armed Forces and National Security.

Text 1

Each version as it was printed, newest first.

  1. Oct 17, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.